Fostering the next generation of diabetes research to achieve health equity.
![](https://cdtr.wustl.edu/files/2021/07/for-website-2-1024x280.png)
The WU-CDTR is a collaboration between Washington University in St. Louis, the Council on Black Health, housed at Drexel University, and the University of Missouri, Columbia. We work to support a national network of investigators conducting cutting-edge research on the root causes of diabetes inequities.
![](https://cdtr.wustl.edu/files/2024/03/Kumanyika-1-0f310fa229906c58.png)
As the lead for the Solutions for Diabetes in Black Americans core, I see this role as a rubric for finding ways to transfer what we do know about broader solutions to other researchers who are interested in being effective in this space.
Shiriki Kumanyika, PhD, MPH
Tools and resources
We have a curated library of research toolkits and webinars that can benefit your work.
Core services
Our research cores offer a range of services that support and enhance diabetes translation research for our members.
Upcoming events
10
Sep
Research highlights
Scholars Say Implementation Science Training Boosted Their Careers (Links to an external site)
WU-CDTR members, Drs. Niko Verdecias-Pellum and Gabriella McLoughlin highlight the impacts of the Institute for Implementation Science Scholars (IS-2).
Podcast: Ross Brownson on The Path to Public Health Transformation (Links to an external site)
Health Affairs‘ Editor-in-Chief Alan Weil interviews WU-CDTR Associate Director, Dr. Ross Brownson of Washington University on his recent paper that details the path towards a transformed public health system and how a focus on social determinants of health and partnerships with diverse sectors can help overcome challenges in the current system.
WU-CDTR at the 84th ADA Scientific Sessions
The 83rd Scientific Sessions, hosted by the American Diabetes Association, will be hosted June 21-24 in Orlando, FL. As the world’s largest meeting on diabetes, the Scientific Sessions is both a leading educational gathering and a unique opportunity to network with colleagues from over 115 countries. Exciting new clinical trial data on novel incretins are […]